EFM
SAGE
E Fund Management’s Sage Therapeutics SAGE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-18,544
| Closed | -$348K | – | 369 |
|
|
2024
Q1 | $348K | Buy |
18,544
+2,062
| +13% | +$38.6K | 0.02% | 254 |
|
|
2023
Q4 | $357K | Sell |
16,482
-4,678
| -22% | -$101K | 0.02% | 209 |
|
|
2023
Q3 | $435K | Buy |
21,160
+13,703
| +184% | +$282K | 0.03% | 147 |
|
|
2023
Q2 | $351K | Sell |
7,457
-1,955
| -21% | -$92K | 0.03% | 198 |
|
|
2023
Q1 | $395K | Buy |
9,412
+824
| +10% | +$34.6K | 0.03% | 170 |
|
|
2022
Q4 | $328K | Sell |
8,588
-2,753
| -24% | -$105K | 0.03% | 215 |
|
|
2022
Q3 | $444K | Buy |
11,341
+446
| +4% | +$17.5K | 0.04% | 153 |
|
|
2022
Q2 | $352K | Buy |
10,895
+2,261
| +26% | +$73K | 0.03% | 208 |
|
|
2022
Q1 | $286K | Buy |
+8,634
| New | +$286K | 0.01% | 211 |
|